Likewise, Le Large and collaborators found elevated levels of microtubule-associated protein 2 (MAP2) in GEM-resistant pancreatic cancer models that were highly sensitive to PTX both in vitro and in vivo (34). This evidence concerns the gene MAP2 and pancreatic neoplasm.